Post-translational regulation of PD-1 protein homeostasis: the ubiquitination-centered crosstalk network

Persistent overexpression of programmed cell death protein 1 (PD-1) on tumor-infiltrating T cells is a key molecular basis for T-cell exhaustion and for the limited efficacy of immune checkpoint blockade. Recent studies have shown that PD-1 is not regulated solely at the transcriptional level. Rather, PD-1 protein abundance is controlled by a multilayered post-translational network in which ubiquitination functions as a central decision point rather than a uniform degradation signal. K48-linked chains generally promote proteasomal turnover, whereas deubiquitination, K63-linked ubiquitination, UFMylation, glycan maturation, and selected trafficking programs can stabilize specific PD-1 pools. Distinct from previous broad surveys of PD-1/PD-L1 post-translational regulation, this review organizes the available evidence along the PD-1 protein life cycle—newly synthesized and incompletely glycosylated precursor, mature plasma-membrane receptor, internalized/recycling receptor, lysosome-directed receptor, nuclear PD-1, and tumor-intrinsic PD-1. We explicitly distinguish mechanisms supported by site-directed, chain-specific, biochemical, or genetic evidence from cellular associations and unresolved models. We also integrate the F-box protein 38 (FBXO38) controversy, phosphorylation-dependent FBW7 and USP5 pathways, NGLY1–MDM2-coupled deglycosylation, UFL1-mediated UFMylation, and membrane trafficking and summarize the evidence and translational limitations in two tables and an integrated schematic. This evidence-graded framework highlights both therapeutic opportunities and the specificity, toxicity, cell-type, and biomarker challenges that must be resolved before PD-1 homeostasis can be targeted clinically.

Authors

Institutions

Publication Details

Journal
Cellular & Molecular Biology Letters
Published
2026-11-12
DOI
https://doi.org/10.1186/s11658-026-01036-1
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Post-translational regulation of PD-1 protein homeostasis: the ubiquitination-centered crosstalk network

高翊軒, Yishan Gao, Anrui Yang, Ying Zhang
Cellular & Molecular Biology Letters
Cancer Immunotherapy and Biomarkers
article

Post-translational regulation of PD-1 protein homeostasis: the ubiquitination-centered crosstalk network

高翊軒, Yishan Gao, Anrui Yang, Ying Zhang
article en

Abstract

Persistent overexpression of programmed cell death protein 1 (PD-1) on tumor-infiltrating T cells is a key molecular basis for T-cell exhaustion and for the limited efficacy of immune checkpoint blockade. Recent studies have shown that PD-1 is not regulated solely at the transcriptional level. Rather, PD-1 protein abundance is controlled by a multilayered post-translational network in which ubiquitination functions as a central decision point rather than a uniform degradation signal. K48-linked chains generally promote proteasomal turnover, whereas deubiquitination, K63-linked ubiquitination, UFMylation, glycan maturation, and selected trafficking programs can stabilize specific PD-1 pools. Distinct from previous broad surveys of PD-1/PD-L1 post-translational regulation, this review organizes the available evidence along the PD-1 protein life cycle—newly synthesized and incompletely glycosylated precursor, mature plasma-membrane receptor, internalized/recycling receptor, lysosome-directed receptor, nuclear PD-1, and tumor-intrinsic PD-1. We explicitly distinguish mechanisms supported by site-directed, chain-specific, biochemical, or genetic evidence from cellular associations and unresolved models. We also integrate the F-box protein 38 (FBXO38) controversy, phosphorylation-dependent FBW7 and USP5 pathways, NGLY1–MDM2-coupled deglycosylation, UFL1-mediated UFMylation, and membrane trafficking and summarize the evidence and translational limitations in two tables and an integrated schematic. This evidence-graded framework highlights both therapeutic opportunities and the specificity, toxicity, cell-type, and biomarker challenges that must be resolved before PD-1 homeostasis can be targeted clinically.

Cellular & Molecular Biology Letters
Capital Medical University (CN), Beijing Obstetrics and Gynecology Hospital (CN)
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon